W

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

商业管理
分享到
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Source：MarketWatch

友情提醒：请广大读者理性看待市场信息，切实提高风险意识。站内所有内容仅系市场信息或相关方观点，不构成任何形式投资建议。

延伸阅读

FTX, Alameda-linked wallets send $75 million in ether to Wintermute, onchain data shows

Onchain analysts PeckShield and EmberCN say the funds moved to a Wintermute wallet, but neither a sale nor the purpose of the transfer have been confirmed.…

Raiffeisen to offer crypto trading across 11 European markets via Bitpanda

Bitpanda will provide crypto infrastructure to Raiffeisen network banks, potentially extending digital asset access to about 18 million customers.…

Why analysts say a diesel export ban could backfire

A ban on U.S. diesel exports could reduce supplies and simultaneously lead to prices rising further, according to analysts. Source：MarketWatch

Here are the hidden flaws in Warsh’s new way of tracking inflation

Economists at Nomura say the new way Kevin Warsh is tracking inflation doesn’t have better predictive power than core readings. Source：MarketWatch

来源：https://www.marketwatch.com/story/this-glp-1-drug-helped-people-maintain-their-weight-loss-in-a-clinical-trial-even-for-those-taking-it-once-a-month-f70929b5